Alterations in prostacyclin and thromboxane formation by chronic cigarette smoke exposure: Temporal relationships and whole smoke vs. gas phase

Publisher Website
Google Scholar
Abstract
Chronic cigarette smoke exposure in vivo causes decreased conversion of [14C]arachidonic acid (AA) to prostacyclin (PGI2) by isolated aortic tissue and increased conversion to thromboxane (TXA2) by isolated platelets from rats. Alterations in the PGI2/TXA2 balance may be part of the mechanism through which smoking increases the risk of cardiovascular disease. To study the influence of smoke exposure duration on this response, male rats were exposed daily to 10 puffs of freshly generated cigarette smoke. Animals were klledd after 1, 4, 14, 28 and 57 days of smoke exposure and 3, 7, 14 and 28 days after cessation of the 57-day of smoke-exposure regimen. Elevated carboxyhemoglobin levels during the smoke-exposure sessions verified smoke (gas phase) inhalation. Statistically significant alterations in prostacyclin synthesis preceded those of thromboxane. A decrease of 20-25% (P2 production from [14C]AA in isolated aortic tissue was found beginning 28 days after smoke was initiated and quickly rebounded when smoke exposure was terminated. Increased production of TXA2 from [14C]AA by isolated platelets became statistically significant (P2/TXA2 balance a second series of experiments divided male and female Sprague-Dawley rats into sham, whole smoke and gas phase groups. Gas phase was produced by passing whole smoke through a Cambridge filter to remove particulate matter. Per cent COHb averaged 1.4 for sham, 7.8 for whole smoke and 9.4 for gas phase groups. After 8 and 12 weeks of exposure, whole smoke decreased aortic PGI2 and increased platelet TXA2 both in male and in female rats. In contrast to whole smoke exposure, 8 or 12 weeks of exposure to gas phase constituents filed to produce any statistically significant alteration in PGI2 and TXA2 formation. It was concluded that changes in PGI2 and TXA2 formation occur readily following initiation or termination of chronic whole smoke exposure and that substances present in the particulate phase of smoke are essential to producing these changes.